Among these parameters, a significant relationship between high KLF10 expression and a higher 5-year survival rate was observed in a number of parameters, including female gender (88.6% vs. 44.9%; HR: 7.045, p = 0.016), non-smokers (62.2% vs. 49.9%; HR: 1.694, p = 0.04), cancer stage T1 (78.9% vs. 50.0%; HR: 3.074, p = 0.017), and cancer stage N0 (73.2% vs. 60.2%; HR:1.779, p = 0.043). The gene discussed is KLF10; the disease is cancer.